Home » Alliance and Double-Crane Announce Memorandum of Understanding
Alliance and Double-Crane Announce Memorandum of Understanding
April 7, 2005
Alliance Pharmaceutical, through its subsidiary PFC Therapeutics, and Beijing Double-Crane Pharmaceutical ("Double-Crane"), today announced that they have entered into a Memorandum of Understanding ("MOU") for the development of Oxygent in The People's Republic of China ("PRC"). Pursuant to the MOU, the parties intend to negotiate a final license agreement whereby Double-Crane will be granted the right to develop and commercialize Oxygent in the PRC.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19613620&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct